Imprisonment, injecting drug use, and bloodborne viruses.
作者信息
Gill O N, Noone A, Heptonstall J
出版信息
BMJ. 1995 Feb 4;310(6975):275-6. doi: 10.1136/bmj.310.6975.275.
Abstract
摘要
相似文献
1
Imprisonment, injecting drug use, and bloodborne viruses.
BMJ. 1995 Feb 4;310(6975):275-6. doi: 10.1136/bmj.310.6975.275.
2
Intravenous drug use and HIV transmission amongst inmates in Scottish prisons.
Br J Addict. 1992 Jan;87(1):35-45. doi: 10.1111/j.1360-0443.1992.tb01898.x.
3
HIV infection in prisons. Most drug injectors stop injecting on entry to prison.
BMJ. 1995 May 13;310(6989):1264. doi: 10.1136/bmj.310.6989.1264.
4
Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
Commun Dis Public Health. 2000 Jun;3(2):121-6.
5
Spread of bloodborne viruses among Australian prison entrants.
BMJ. 1995 Feb 4;310(6975):285-8. doi: 10.1136/bmj.310.6975.285.
6
Comparison of sexual behaviour and risk of HIV transmission of Scottish inmates, with or without a history of intravenous drug use.
AIDS Care. 1992;4(1):53-67. doi: 10.1080/09540129208251620.
7
Interventions to reduce HIV transmission related to injecting drug use in prison.
Lancet Infect Dis. 2009 Jan;9(1):57-66. doi: 10.1016/S1473-3099(08)70305-0.
8
AIDS behind bars: preventing HIV spread among incarcerated drug injectors.
AIDS. 1995 Aug;9(8):825-32.
9
A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Indian J Public Health. 1995 Jul-Sep;39(3):86-92.
10
Preventing HIV transmission in prison: a tale of medical disobedience and Swiss pragmatism.
Lancet. 1995 Dec 9;346(8989):1507-8. doi: 10.1016/s0140-6736(95)92047-1.
引用本文的文献
1
Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners.
BMC Infect Dis. 2007 Aug 30;7:100. doi: 10.1186/1471-2334-7-100.
2
Drug testing in Canadian jails: to what end?
Can J Public Health. 2000 Jan-Feb;91(1):26-8. doi: 10.1007/BF03404247.
3
Prison rights: mandatory drugs tests and performance indicators for prisons.
BMJ. 1996 Jun 1;312(7043):1411-3.
4
HIV infection in prisons. Testing in prison is uncommon.
BMJ. 1995 May 13;310(6989):1265. doi: 10.1136/bmj.310.6989.1265a.
5
HIV infection in prisons. High risk behaviour is common in prisons in Berlin.
BMJ. 1995 May 13;310(6989):1264. doi: 10.1136/bmj.310.6989.1264a.
本文引用的文献
1
Transmission of HIV in prison. Evidence of risk.
BMJ. 1993 Sep 4;307(6904):623. doi: 10.1136/bmj.307.6904.623.
2
Evidence of intraprison spread of HIV infection.
Arch Intern Med. 1994 Apr 11;154(7):793-5.
3
Drug injection and HIV prevalence in inmates of Glenochil prison.
BMJ. 1995 Feb 4;310(6975):293-6. doi: 10.1136/bmj.310.6975.293.
4
Outbreak of HIV infection in a Scottish prison.
BMJ. 1995 Feb 4;310(6975):289-92. doi: 10.1136/bmj.310.6975.289.
5
Inside methodology: HIV surveillance in prisons.
AIDS. 1994 Sep;8(9):1345-6. doi: 10.1097/00002030-199409000-00021.
6
Total screening of blood donations for Australia (hepatitis associated) antigen and its antibody.
Br Med J. 1972 Mar 11;1(5801):663-4. doi: 10.1136/bmj.1.5801.663.
7
HIV/AIDS in prisons.
Scott Med J. 1992 Oct;37(5):132-7. doi: 10.1177/003693309203700502.
8
Sensitivity of serological assays to identify blood donors with hepatitis C viraemia.
Lancet. 1992 Apr 25;339(8800):1018-9. doi: 10.1016/0140-6736(92)90538-e.
Zotero 插件